ATE126213T1 - Pyrrolaldehydderivate. - Google Patents

Pyrrolaldehydderivate.

Info

Publication number
ATE126213T1
ATE126213T1 AT90124977T AT90124977T ATE126213T1 AT E126213 T1 ATE126213 T1 AT E126213T1 AT 90124977 T AT90124977 T AT 90124977T AT 90124977 T AT90124977 T AT 90124977T AT E126213 T1 ATE126213 T1 AT E126213T1
Authority
AT
Austria
Prior art keywords
pyrrolaldehyde
derivatives
pyrrolealdehyde
carbamoyloxy
arteriosclerosis
Prior art date
Application number
AT90124977T
Other languages
English (en)
Inventor
Masao Taniguchi
Tadashi Shirasaka
Kohei Umezu
Mayumi Hirata
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of ATE126213T1 publication Critical patent/ATE126213T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT90124977T 1989-12-20 1990-12-20 Pyrrolaldehydderivate. ATE126213T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33025689 1989-12-20

Publications (1)

Publication Number Publication Date
ATE126213T1 true ATE126213T1 (de) 1995-08-15

Family

ID=18230608

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90124977T ATE126213T1 (de) 1989-12-20 1990-12-20 Pyrrolaldehydderivate.

Country Status (6)

Country Link
US (1) US5153217A (de)
EP (1) EP0434070B1 (de)
KR (1) KR910011777A (de)
AT (1) ATE126213T1 (de)
CA (1) CA2032421A1 (de)
DE (1) DE69021525T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06104658B2 (ja) * 1988-06-23 1994-12-21 三菱化成株式会社 ピロールカルボン酸誘導体
DE4020851A1 (de) * 1990-06-29 1992-01-02 Cassella Ag 2-(aminoalkyl)-pyrrolaldehyde, verfahren zu ihrer herstellung und ihre verwendung
ME00415B (me) * 2000-02-15 2011-10-10 Pharmacia & Upjohn Co Llc Pirol supstituisani 2-indol protein kinazni inhibitori
AR042586A1 (es) 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
EP1434774A1 (de) 2001-10-10 2004-07-07 Sugen, Inc. 3-(4-substituierte heterocyclyl)-pyrrol-2-ylmethylidene)-2-indolinone derivate als protein-kinase-inhibitoren

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2500713A (en) * 1946-11-13 1950-03-14 American Cyanamid Co Monoalkamine esters of pyrrole-3-carboxylic acids
US2479971A (en) * 1946-11-13 1949-08-23 American Cyanamid Co Monoalkamine esters of pyrrole-3-carboxylic acids
US2479972A (en) * 1946-11-14 1949-08-23 American Cyanamid Co Monoalkamine esters of pyrrole-5-carboxylic acids
US4382143A (en) * 1979-07-23 1983-05-03 American Cyanamid Company Hypolipidemic and antiatherosclerotic novel (monosubstituted-amino)heteroaryl carboxylic acids and analogs
US4560700A (en) * 1985-02-08 1985-12-24 Merrell Dow Pharmaceuticals Inc. Pyrrole-3-carboxylate cardiotonic agents
US4824958A (en) * 1986-06-13 1989-04-25 Warner-Lambert Company Process for the preparation of n-1H-tetrazol-5-yl-2-pyrrole carboxamides

Also Published As

Publication number Publication date
EP0434070B1 (de) 1995-08-09
DE69021525D1 (de) 1995-09-14
US5153217A (en) 1992-10-06
EP0434070A2 (de) 1991-06-26
KR910011777A (ko) 1991-08-07
DE69021525T2 (de) 1996-03-21
EP0434070A3 (en) 1992-03-18
CA2032421A1 (en) 1991-06-21

Similar Documents

Publication Publication Date Title
DK0379979T3 (de)
FI906204A (fi) Menetelmä farmaseuttisesti vaikuttavien peptidiyhdisteiden valmistamiseksi
PH30811A (en) Polypeptide compound and a process for preparationthereof.
DK0495982T3 (da) Bicyklisk pyrimidinderivat, fremgangsmåde til fremstilling deraf og farmaceutisk præparat omfattende dette som en aktiv bestanddel
AU582601B2 (en) Benzoxazol-and benzothiazolamine derivatives
AU5910996A (en) Pyrrole derivatives and medicinal composition
FI893701A (fi) Menetelmä antipsykoottisten 3-piperatsinyylibentsatsolijohdannaisten valmistamiseksi
NZ229347A (en) Substituted cephalosporin derivatives; pharmaceutical compositions, preparatory processes and intermediates
ATE126213T1 (de) Pyrrolaldehydderivate.
EP0326379A3 (de) Arzneimittel für Leberkrankheiten und Piperazin-Derivate
EP0711554A4 (de) Antidepressivum
AU4209693A (en) Novel piperidine derivatives and process for preparation thereof
DE69024154D1 (de) Pyrimidoindolderivate und Verfahren zu ihrer Herstellung
EP0450232A3 (en) P-guanidino benzoic acid derivatives for treatment of cerebrovascular contraction
NZ329604A (en) Isoxazole derivatives substituted by an amino, guanidinyl or azacycloalkyl-oxy, -sulphinyl or -sulphenyl group, pharmaceutical compositions comprising them

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties